MeiraGTx Holdings (MGTX) Cash from Financing Activities (2017 - 2025)

MeiraGTx Holdings (MGTX) reported Cash from Financing Activities of $5.3 million for Q4 2025, up 25.54% on a YoY basis from $4.2 million in Q4 2024, and up 2532.88% quarter-over-quarter from -$219000.0 in Q3 2025.

MeiraGTx Holdings (MGTX) Cash from Financing Activities (2017 - 2025) Analysis & Trends

MeiraGTx Holdings has reported Cash from Financing Activities for 9 years, with the latest figure at $5.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 25.54% year-over-year to $5.3 million; the trailing twelve-month figure through Dec 2025 stood at $12.3 million (down 77.5% YoY), and the FY2025 full-year result was $12.3 million, down 77.5% from the prior year.
  • Cash from Financing Activities for Q4 2025 stood at $5.3 million, up from -$219000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $72.9 million in Q3 2022, with the low at -$2.6 million in Q1 2022.
  • Historically, Cash from Financing Activities has averaged $13.0 million across 5 years, with a median of $1.6 million in 2024.
  • The largest YoY upside for Cash from Financing Activities was 134990.74% in 2022 against a maximum downside of 1998.53% in 2022.
  • MeiraGTx Holdings' Cash from Financing Activities stood at $1.3 million in 2021, then surged by 1817.61% to $24.8 million in 2022, then increased by 11.59% to $27.7 million in 2023, then slumped by 84.68% to $4.2 million in 2024, then gained by 25.54% to $5.3 million in 2025.
  • The last three Cash from Financing Activities figures came in at $5.3 million (Q4 2025), -$219000.0 (Q3 2025), and $5.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 MeiraGTx Holdings 910.47 Mn 844.54 Mn 74.89 Mn 5.33 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.33 Mn
Dec 31, 2025 5.33 Mn
Sep 30, 2025 -219,000.00
Sep 30, 2025 -219,000.00
Jun 30, 2025 5.45 Mn
Jun 30, 2025 5.45 Mn
Mar 31, 2025 1.71 Mn
Mar 31, 2025 1.71 Mn
Dec 31, 2024 4.24 Mn
Dec 31, 2024 4.24 Mn
Sep 30, 2024 49.96 Mn
Sep 30, 2024 49.96 Mn
Jun 30, 2024 1.60 Mn
Jun 30, 2024 1.60 Mn
Mar 31, 2024 -1.27 Mn
Mar 31, 2024 -1.27 Mn
Dec 31, 2023 27.71 Mn
Dec 31, 2023 27.71 Mn
Sep 30, 2023 -404,000.00
Sep 30, 2023 -404,000.00